Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veins | 2 | 2020 | 104 | 0.650 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2020 | 13 | 0.650 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2020 | 32 | 0.630 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2020 | 86 | 0.630 |
Why?
|
| Angioplasty, Balloon | 1 | 2020 | 162 | 0.590 |
Why?
|
| Device Removal | 1 | 2020 | 223 | 0.570 |
Why?
|
| Catheter Ablation | 5 | 2021 | 248 | 0.570 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 132 | 0.570 |
Why?
|
| Atrial Fibrillation | 9 | 2021 | 699 | 0.490 |
Why?
|
| Cardiac Pacing, Artificial | 5 | 2025 | 120 | 0.410 |
Why?
|
| Heart Conduction System | 4 | 2021 | 145 | 0.380 |
Why?
|
| Ethanol | 2 | 2021 | 166 | 0.310 |
Why?
|
| Heart Failure | 2 | 2020 | 2428 | 0.280 |
Why?
|
| Sick Sinus Syndrome | 1 | 2025 | 13 | 0.230 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2025 | 61 | 0.220 |
Why?
|
| Pacemaker, Artificial | 2 | 2025 | 179 | 0.220 |
Why?
|
| Tachycardia, Ventricular | 5 | 1997 | 207 | 0.210 |
Why?
|
| Atrial Flutter | 3 | 1999 | 34 | 0.210 |
Why?
|
| Equipment Design | 3 | 2025 | 604 | 0.200 |
Why?
|
| Defibrillators, Implantable | 4 | 1998 | 200 | 0.200 |
Why?
|
| Heart Rate | 3 | 2025 | 586 | 0.190 |
Why?
|
| Atrial Appendage | 1 | 2021 | 51 | 0.170 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 59 | 0.170 |
Why?
|
| Punctures | 1 | 2020 | 63 | 0.160 |
Why?
|
| Pulmonary Veins | 1 | 2021 | 167 | 0.150 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 238 | 0.150 |
Why?
|
| Tachycardia, Supraventricular | 3 | 1996 | 110 | 0.140 |
Why?
|
| Wolff-Parkinson-White Syndrome | 2 | 1995 | 73 | 0.140 |
Why?
|
| Sotalol | 1 | 1997 | 34 | 0.140 |
Why?
|
| Amiodarone | 1 | 1997 | 46 | 0.140 |
Why?
|
| Aged | 14 | 2025 | 21448 | 0.130 |
Why?
|
| Treatment Outcome | 9 | 2021 | 13094 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1997 | 227 | 0.120 |
Why?
|
| Electrocardiography | 5 | 2025 | 997 | 0.110 |
Why?
|
| Coronary Disease | 2 | 1999 | 685 | 0.110 |
Why?
|
| Coronary Vessels | 2 | 1995 | 540 | 0.110 |
Why?
|
| Middle Aged | 13 | 2025 | 28912 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 676 | 0.100 |
Why?
|
| Intraoperative Complications | 1 | 1994 | 164 | 0.100 |
Why?
|
| Electric Countershock | 3 | 1998 | 74 | 0.100 |
Why?
|
| Stroke | 1 | 2021 | 1079 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1163 | 0.090 |
Why?
|
| Digoxin | 1 | 2010 | 43 | 0.080 |
Why?
|
| Male | 14 | 2025 | 65478 | 0.080 |
Why?
|
| Infusions, Intravenous | 2 | 2021 | 569 | 0.080 |
Why?
|
| Female | 14 | 2021 | 71395 | 0.070 |
Why?
|
| Humans | 20 | 2025 | 133181 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2010 | 1240 | 0.060 |
Why?
|
| Safety | 2 | 1995 | 217 | 0.050 |
Why?
|
| Electrophysiology | 4 | 1999 | 281 | 0.050 |
Why?
|
| Heart Atria | 1 | 2025 | 334 | 0.050 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 1999 | 62 | 0.040 |
Why?
|
| Tachycardia | 1 | 2020 | 68 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 250 | 0.040 |
Why?
|
| Prospective Studies | 4 | 1999 | 6571 | 0.040 |
Why?
|
| Atrial Function | 1 | 1999 | 15 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 2 | 1997 | 267 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 1136 | 0.030 |
Why?
|
| Ventricular Fibrillation | 1 | 1997 | 52 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 1997 | 5435 | 0.030 |
Why?
|
| Recurrence | 1 | 2021 | 1469 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 1307 | 0.030 |
Why?
|
| Ventricular Function, Left | 2 | 1997 | 546 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 1997 | 122 | 0.030 |
Why?
|
| Survival Rate | 2 | 1997 | 2204 | 0.030 |
Why?
|
| Adult | 5 | 2021 | 31616 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1994 | 35 | 0.030 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 1994 | 32 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 1997 | 823 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 1994 | 158 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 1995 | 484 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1996 | 475 | 0.020 |
Why?
|
| Adolescent | 2 | 2021 | 20549 | 0.020 |
Why?
|
| Algorithms | 1 | 1997 | 1730 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 7137 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2010 | 436 | 0.020 |
Why?
|
| Electric Stimulation | 2 | 1999 | 288 | 0.020 |
Why?
|
| Risk Assessment | 1 | 1997 | 3715 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9921 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1350 | 0.020 |
Why?
|
| Time Factors | 1 | 1995 | 6541 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 1999 | 3043 | 0.010 |
Why?
|
| Hypertension | 1 | 2010 | 1402 | 0.010 |
Why?
|
| United States | 1 | 1994 | 11711 | 0.010 |
Why?
|
| Electrodes | 1 | 1997 | 91 | 0.010 |
Why?
|
| Electric Impedance | 1 | 1997 | 68 | 0.010 |
Why?
|
| Linear Models | 1 | 1999 | 719 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 255 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 10935 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 1996 | 85 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1997 | 525 | 0.010 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1996 | 213 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1999 | 2286 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1997 | 519 | 0.010 |
Why?
|
| Research Design | 1 | 1996 | 757 | 0.010 |
Why?
|
| Child | 1 | 1996 | 25847 | 0.000 |
Why?
|